OptimizeRx's market cap is currently ―. The company's EPS TTM is $-0.81; its P/E ratio is -12.29; OptimizeRx is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 28.37M	$ 16.33M	$ 13.82M	$ 13.00M	$ 19.65M
Gross Profit	$ 17.84M	$ 9.80M	$ 13.82M	$ 7.43M	$ 12.45M
EBIT	$ -8.11M	$ -2.87M	$ -4.16M	$ -6.40M	$ -325.84K
EBITDA	$ -6.89M	$ -2.40M	$ -3.70M	$ -5.93M	$ 1.70M
Net Income Common Stockholders	$ -4.14M	$ -2.87M	$ -4.16M	$ 33.73M	$ -325.84K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 13.85M	$ 53.62M	$ 62.74M	$ 73.70M	$ 74.14M
Total Assets	$ 183.37M	$ 123.93M	$ 121.32M	$ 131.69M	$ 134.65M
Total Debt	$ 36.82M	$ 148.64K	$ 14.54K	$ 212.51K	$ 234.43K
Net Debt	$ 22.97M	$ -53.47M	$ -62.73M	$ -73.49M	$ -73.91M
Total Liabilities	$ 56.82M	$ 7.82M	$ 5.51M	$ 7.73M	$ 8.54M
Stockholders Equity	$ 126.55M	$ 116.11M	$ 115.82M	$ 123.96M	$ 126.11M
Cash Flow	-
Free Cash Flow	$ -6.25M	$ 1.44M	$ -2.39M	$ -114.91K	$ 2.94M
Operating Cash Flow	$ -6.26M	$ 1.47M	$ -2.37M	$ -86.33K	$ 2.80M
Investing Cash Flow	$ -26.00M	$ -1.01M	$ 3.22M	$ -1.55M	$ -18.48M
Financing Cash Flow	$ 36.19M	$ -349.43K	$ -7.49M	$ -129.79K	$ -7.44M

Currency in USD

OptimizeRx Earnings and Revenue History

Income Statement >

OptimizeRx Debt to Assets

Balance Sheet >

OptimizeRx Cash Flow

Cash Flow >

OptimizeRx Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing